logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
E

Emmanuel Seront

UCLouvain
H指数:22
被引数:2,422

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world treatment patterns and clinical outcomes in patients with non-muscle invasive bladder cancer: a nationwide evaluation

非肌肉浸润性膀胱癌患者的真实世界治疗模式与临床结局：一项全国性评估

World Journal of Urology
IF2.9
2026-08-130
OA
Yannic Raskin; Frederic Baekelandt; Karel Decaestecker; Emmanuel Seront; Guillaume Grisay; Thomas De Sutter; Michel Bailly; Jean-Paul Noujeim; Hannelore Maes; Lise De Smedt; David Waltregny; Walther Brochier; Thierry Roumeguère; Bertrand Tombal
Baseline Disease Characteristics and Platinum Sensitivity as Predictors of Outcomes in Sequential Therapy with Platinum-Based Chemotherapy, Avelumab Maintenance, and Enfortumab Vedotin in Advanced Urothelial Carcinoma (ARON-2EV Study)

基线疾病特征和铂类药物敏感性作为顺铂为基础化疗、阿维鲁姆单抗维持治疗和恩沃利单抗维多汀序贯疗法在晚期尿路上皮癌中的预后预测因素（ARON-2EV研究）

Targeted Oncology
IF4
2026-07-290
PRE
Mimma Rizzo; Sebastiano Buti; Ondřej Fiala; Lorena Incorvaia; Javier Molina-Cerrillo; Maria T. Bourlon; Wataru Fukuokaya; Fumihiko Urabe; Se Hoon Park; Karl Mayrhofer; Renate Pichler; Dora Niedersuess-Beke; Tarek Taha; Thomas Büttner; Aristotelis Bamias; Emmanuel Seront; Daniele Santini; Luciano Stumbo; Alejo Rodriguez-Vida; Francesco Massari; Fernando Sabino Marques Monteiro; Andrey Soares; Enrique Grande; Matteo Santoni
Case Report: Cardiac metastasis from urothelial carcinoma with predominant squamous differentiation in a young woman: first reported case treated with enfortumab vedotin plus pembrolizumab

病例报告：年轻女性尿路上皮癌伴主要鳞状分化的心脏转移：首个接受恩沃利单抗联合帕博利珠单抗治疗的病例

Frontiers in Oncology
IF3.3
2026-05-200
OA
AV Alix Vansteeger; EM El Mamoune El Ghali Benlemlih; AD Antoine Delmarche; ST Stéphane Thiry; HD Hélène Dano; JC Justine Castaigne; VP Vassiliki Pasoglou; SV Sandy Van Nieuwenhove; BG Bernhard Gerber; GA Gaby Aphram; QA Qaid Ahmed Shagera; CB Christophe Beauloye; RG Rachel Galot; CV Cédric van Marcke; ES Emmanuel Seront
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study

恩扎卢替尼在转移性激素敏感前列腺癌中的应用：国际、多中心真实世界ARON-3研究的结果

Prostate Cancer and Prostatic Diseases
IF5.8
2026-01-080
OAAI
Thomas Büttner; Mimma Rizzo; Laura Bernal Vaca; Javier Molina-Cerrillo; Teresa Alonso-Gordoa; Alvaro Juárez; Tomas Buchler; Emmanuel Seront; Jakub Kucharz; María Natalia Gandur Quiroga; Maria T. Bourlon; Martin Bögemann; Jindrich Kopecky; Pasquale Rescigno; Ondrej Fiala; Alejo Rodriguez-Vida; Zin W. Myint; Yüksel Ürün; Sarah Scagliarini; Alexandr Poprach; Diana Matthews; Haoran Li; Alessandro Rizzo; Alessandra Mosca; Edoardo Lenci; Bohuslav Melichar; Mike Wenzel; Philipp Mandell; Francesco Massari; Emmanuel S. Antonarakis; Matteo Santoni
Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)

与毒性相关的免疫治疗停药及结局：接受基于免疫联合治疗方案的晚期肾细胞癌患者（ARON-1研究）

International Journal of Cancer
IF4.7
2025-11-040
PRE
Javier Molina-Cerrillo; Giandomenico Roviello; Maria T. Bourlon; Hana Studentova; Ondrej Fiala; Linda Cerbone; Jakub Kucharz; Jawaher Ansari; Annalisa Zeppellini; Tarek Taha; Sebastiano Buti; Yüksel Ürün; Sarah Scagliarini; Haoran Li; Kaisa Sunela; Se Hoon Park; Mimma Rizzo; Anca Zgura; Rita Chiari; Emmanuel Seront; Martina Catalano; Marwan Ghosn; Alessandra Filosa; Andrey Soares; Francesco Massari; Fernando Sabino Marques Monteiro; Enrique Grande; Camillo Porta; Sergio Bracarda; Matteo Santoni
177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study

177Lu-PSMA 与 cabazitaxel 在去势抵抗性前列腺癌患者中的真实世界疗效与安全性数据：ARON-3 研究结果

European Journal of Cancer
IF7.1
2025-09-120
PREAI
Philipp Mandel; Daniel Groener; Giulia Follacchio; Yüksel Ürün; Maria T. Bourlon; Amir Sabet; Frank Grünwald; Deniz Tural; Thomas Büttner; Ray Manneh Kopp; Tarek Taha; Felix KH Chun; Gaetano Facchini; Zin W Myint; Emmanuel Seront; Vincenza Conteduca; María Natalia Gandur Quiroga; Gaetano Aurilio; Georgia Anguera Palacios; Martin Bögemann; Giandomenico Roviello; Marc R Matrana; Enrico Sammarco; Martin Ignacio Zapata Laguado; Luca Galli; Jawaher Ansari; Linda Danielli; Javier Molina-Cerrillo; Pasquale Rescigno; Sati Coskun Yazgan; Diogo Assed Bastos; Abdul Rahman Jazieh; Fernando Sabino Marques Monteiro; Andrey Soares; Francesco Massari; Mike Wenzel; Francesca Capoccetti; Matteo Santoni
Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset

预后免疫疗法评分（PIS）在经帕博利珠单抗治疗的晚期尿路上皮癌患者中的真实世界数据及ARON-2数据集验证

Clinical & Experimental Metastasis
IF3.2
2025-09-060
PRE
Alessandro Rizzo; Anas Zayed; Elsa Vitale; Sebastiano Buti; Hideki Takeshita; Simon Crabb; Giandomenico Roviello; Emmanuel Seront; Jose Carlos Tapia; Sarah Scagliarini; Lazar Popovic; Ray Manneh Kopp; Halima Abahssain; Mimma Rizzo; Fernando Sabino Marques Monteiro; Raffaella Massafra; Oronzo Brunetti; Daniele Santini; Yüksel Ürün; Rodolfo Montironi; Veronica Mollica; Francesco Massari; Andrey Soares; Matteo Santoni
Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial

avelumab为基础的新辅助疗法在肌肉浸润性膀胱癌患者中的应用（AURA Oncodistinct-004）：一项多中心二期临床试验

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2025-05-240
OA
Blanc, Jeremy; Carnot, Aurelien; Barthelemy, Philippe; Casert, Vinciane; Sautois, Brieuc; van den Brande, Jan; Vanhaudenarde, Vincent; Staudacher, Lionel; Seront, Emmanuel; Debien, Veronique; Ameye, Lieveke; Kotecki, Nuria; Rothe, Francoise; Rorive, Sandrine; Fantoni, Jean-Christophe; Tricard, Thibault; Roumeguere, Thierry; Awada, Ahmad; Chanza, Nieves Martinez
Stereotactic body radiotherapy for lung oligometastatic prostate cancer: An international retrospective multicenter study

立体定向体部放射治疗用于肺寡转移性前列腺癌：一项国际性回顾性多中心研究

clinical translational oncology
IF2.7
2025-05-010
OAAI
Roge, Maximilien; Bowden, Patrick; Conway, Paul; Franzese, Ciro; Scorsetti, Marta; Seront, Emmanuel; Blanchard, Pierre; Terlizzi, Mario; Khalifa, Jonathan; Pasquier, Corentin; Shick, Ulrike; Siva, Shankar; Paul, Julie; Supiot, Stephane
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)

一项关于monalizumab和durvalumab在复发性/转移性头颈鳞状细胞癌患者中的II期研究：EORTC-HNCG-1559试验（UPSTREAM）中I2组的成果

ESMO OPEN
IF8.3
2025-05-010
OAAI
Galot, R.; Le Tourneau, C.; Licitra, L.; Guigay, J.; Kong, A.; Tinhofer, I.; Even, C.; Daste, A.; Henry, S.; Borel, C.; Abdeddaim, C.; Seront, E.; Prevost, J. B.; Rutten, A.; Saada-Bouzid, E.; Rolland, F.; Bonomo, P.; Rasschaert, M.; Dirix, L.; Olungu, C.; Tsechilidou, K.; Govaerts, A. S.; Fortpied, C.; Joaquim, A.; Machiels, J. P.
Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2EV study
CLINICAL & EXPERIMENTAL METASTASIS
IF3.2
2025-02-200
OAAI
Fiala, Ondrej; Buti, Sebastiano; Fujita, Kazutoshi; de Liano, Alfonso Gomez; Fukuokaya, Wataru; Kimura, Takahiro; Yanagisawa, Takafumi; Giannatempo, Patrizia; Angel, Martin; Mennitto, Alessia; Molina-Cerrillo, Javier; Bourlon, Maria T.; Soares, Andrey; Takeshita, Hideki; Calabro, Fabio; Ortega, Cinzia; Kucharz, Jakub; Milella, Michele; Seront, Emmanuel; Park, Se Hoon; Tural, Deniz; Benedetti, Giovanni; Urun, Yuksel; Battelli, Nicola; Melichar, Bohuslav; Poprach, Alexandr; Buchler, Tomas; Kopecky, Jindrich; Conteduca, Vincenza; Monteiro, Fernando Sabino Marques; Massari, Francesco; Gupta, Shilpa; Santoni, Matteo

研究方向

暂未获取到该数据
F
Francesco Massari
H 指数:65论文数:869被引数:1.8万
O
Ondřej Fiala
H 指数:23论文数:311被引数:1,921
M
Matteo Santoni
H 指数:64论文数:636被引数:1.4万
M
Miikka Vikkula
H 指数:83论文数:950被引数:2.6万
S
Sebastiano Buti
H 指数:44论文数:656被引数:7,590
J
Javier Molina‐Cerrillo
H 指数:23论文数:153被引数:1,802
L
Laurence M. Boon
H 指数:63论文数:205被引数:1.6万
F
Fernando Sabino Marques Monteiro
H 指数:16论文数:125被引数:1,149
J
Jakub Kucharz
H 指数:17论文数:92被引数:1,077
Z
Zin Myint
H 指数:17论文数:155被引数:1,337